Explore more publications!
Massachusetts Weekly
Got News to Share?

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 10, 2025

Glasswing Ventures Raises Oversubscribed $200M Fund III to Accelerate AI-native and Frontier Technology Adoption in the Enterprise
November 10, 2025

Glasswing Ventures Raises Oversubscribed $200M Fund III to Accelerate AI-native and Frontier Technology Adoption in the Enterprise

Indeterminate GlobeNewswire
HARD MTN DEW LAUNCHES FIRST-EVER DRINKABLE HOLIDAY CARDS
November 10, 2025

HARD MTN DEW LAUNCHES FIRST-EVER DRINKABLE HOLIDAY CARDS

Indeterminate GlobeNewswire
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials
November 10, 2025

Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials

Indeterminate GlobeNewswire
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors
November 10, 2025

Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors

Indeterminate GlobeNewswire
Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility
November 10, 2025

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

Indeterminate GlobeNewswire
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
November 10, 2025

Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia

Indeterminate GlobeNewswire
Voyager Reports Third Quarter 2025 Financial and Operating Results
November 10, 2025

Voyager Reports Third Quarter 2025 Financial and Operating Results

Indeterminate GlobeNewswire
Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
November 10, 2025

Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer

Indeterminate GlobeNewswire
Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors
November 10, 2025

Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors

Indeterminate GlobeNewswire
Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025
November 10, 2025

Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025

Indeterminate GlobeNewswire
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025

Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
November 10, 2025

Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships

Indeterminate GlobeNewswire
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
November 10, 2025

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 10, 2025

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025
November 10, 2025

Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025

Indeterminate GlobeNewswire
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
November 10, 2025

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

Indeterminate GlobeNewswire
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
November 10, 2025

Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 10, 2025

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Lifeward to Report Third Quarter Financial Results on November 14, 2025
November 10, 2025

Lifeward to Report Third Quarter Financial Results on November 14, 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions